title: Selenium, genetic variation, and prostate cancer risk: epidemiology reflects back on selenium and vitamin E cancer prevention trial.
authors.forename: Elizabeth A
authors.initials: EA
authors.lastname: Platz
authors.forename: Scott M
authors.initials: SM
authors.lastname: Lippman
mesh_terms: D017677:Age Distribution; D000368:Aged; D000369:Aged, 80 and over; D003430:Cross-Sectional Studies; D019587:Dietary Supplements; D014644:Genetic Variation; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D011322:Primary Prevention / Q000379:methods; D011379:Prognosis; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000453:epidemiology / Q000235:genetics / Q000517:prevention & control*; D016032:Randomized Controlled Trials as Topic; D018570:Risk Assessment; D012643:Selenium / Q000627:therapeutic use*; D012680:Sensitivity and Specificity; D016019:Survival Analysis; D016896:Treatment Outcome; D014810:Vitamin E / Q000627:therapeutic use*
chemical_list: D014810:Vitamin E; D012643:Selenium